INTRODUCTION

RESULTS

CONCLUSIONS

METHODS

OBJECTIVE

Subjects

Study design

Assessments

TM Weber,1 CE Arrowitz,1 U Scherdin,2 AM Schoelermann,2 A Filbry2
1Beiersdorf Inc, Wilton, CT, USA; 2Beiersdorf AG, Hamburg, Germany

A Moisturizing Spray Ointment to Help Alleviate Dry Skin Symptoms 
Associated with Atopic Eczema, Psoriasis, and Xerosis

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

55% 

6% 

35% 

2% 

Atopic Eczema 
Xerosis 
Psoriasis 
Ichthyosis 

N=80 

2.29

1.61

0.34

0.86

0.51 

0.13

0

0.5

1.0

1.5

2.0

2.5

Dryness Scaling Cracks 

M
ea

n
 C

lin
ic

al
 G

ra
d

in
g

 S
co

re

*

*

*

OBS=Aquaphor Ointment Body Spray

*p<0.0001 vs Baseline 

N=80 

Baseline End of Study

0

20

40

60

Severe/
Very Severe

Moderate Slight None

Severe/
Very Severe

Moderate Slight None

Severe/
Very Severe

Moderate Slight None

0

20

40

60

0
25

50

75

Reduction in Dryness

Reduction in Scaling

Reduction in Cracks

N=70 

N=20 

End of Study

0.59

1.39 1.39

1.1

0.15

0.81

0.41 0.39

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

Burning Erythema Itching Tightness

M
ea

n
 C

lin
ic

al
 G

ra
d

in
g

 S
co

re

*

*

* *

OBS=Aquaphor Ointment Body Spray 

*p<0.0001 vs Baseline 

N=80 

Baseline End of Study

Reduction in
Itching

Reduction in
Erythema

0

20

40

60

0

20

40

60

%
 o

f 
Su

b
je

ct
s 

%
 o

f 
Su

b
je

ct
s 

N=62

N=57

Reduction in
Burning

Reduction in
Tightness

OBS=Aquaphor Ointment Body Spray
Mean Duration of Treatment=16.2 days 

%
 o

f 
Su

b
je

ct
s 

%
 o

f 
Su

b
je

ct
s 

0

20

40

60

0

20

40

60

80 N=35

N=52

Severe/
Very Severe

Moderate Slight None

Severe/
Very Severe

Moderate Slight None

Severe/
Very Severe

Moderate Slight None

Severe/
Very Severe

Moderate Slight None

Progression to Reduced Symptom Severity 

Baseline End of Study

p

p


	FC17PosterBeiersdorfWeberMoisturizingSpray.pdf